by Bruce Sylvester – KRAS exon 2 mutations are independent predictors of time to recurrence or disease-free survival among patients with stage III distal colon cancer who are receiving… read more.
by Bruce Sylvester – Metastatic colorectal cancer patients who achieved early response to first-line chemotherapy also achieved significantly higher rates of prolonged survival, compared to patients who did… read more.
by Bruce Sylvester – Survival based on primary site of disease is not significantly different among metastatic colorectal cancer patients, Australian researchers reported in a poster presentation at… read more.
by Bruce Sylvester – Metformin therapy at 500 twice daily (BID) is not protective against heart failure in non-diabetic patients following a heart attack, researchers reported on March… read more.
by Bruce Sylvester – Chronic obstructive pulmonary disease (COPD) patients involved in moderate to vigorous physical activity are at a lower risk of hospital readmission within 30 days… read more.
by Bruce Sylvester – Researchers from the Joints on Glucosamine study (JOG) report that oral glucosamine supplementation does not reduce knee cartilage deterioration in osteoarthritis or improve knee… read more.
by Bruce Sylvester – Using ordinary instrumentation plus a computer during nocturnal insulin delivery, scientists have found a method to predict and prevent dangerously low overnight blood sugars… read more.
Emerging uses of FDA approved drugs – by Bruce Sylvester – Over half of depressed subjects in a newly reported study who were injected with onabotulinumtoxinA (OBA/Botox) achieved… read more.
by Bruce Sylvester – Emerging uses of FDA approved drugs – Eplerenone, a drug used to reduce the risk of death in patients with heart failure, shows significant… read more.
by Bruce Sylvester – Emerging uses of FDA approved drugs – Immunosuppresant drugs used to prevent organ rejection after transplantation could become used in fighting persistent HIV infection,… read more.
by Bruce Sylvester – Emerging uses of FDA-approved drugs – Treatment with acetazolamide plus a low-sodium weight-reduction diet for patients diagnosed with idiopathic intracranial hypertension (IIH)mand mild vision… read more.
by Bruce Sylvester – A 15% drop in dietary salt use from 2003-2011 in England and a 40% drop in deaths from heart disease and stroke during the… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
